Emergent BioSolutions (EBS) Current Assets (2010 - 2026)
Emergent BioSolutions (EBS) recorded Current Assets of $558.2 million in Q3 2026, down 29.1% from $786.9 million a year earlier and down 16.2% from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Emergent BioSolutions reported Current Assets of $662.5 million, up 10.7% from FY2024.
- Annual Current Assets has a five-year compound annual growth rate of -11.1% (FY2020 to FY2025).
- Across earlier years, Current Assets came in at $598.7 million in FY2024 (-11.9%), $679.5 million in FY2023 (-43.9%), $1.21 billion in FY2022 (-4.7%) and $1.27 billion in FY2021 (+6.2%).
- The Q3 2026 figure is the lowest quarterly Current Assets since Q1 2019.
- On a year-over-year basis, Current Assets has declined for three consecutive quarters, with an average decline of 1.9% over the last eight quarters.
- Peak year-over-year performance for Current Assets in the last five years was growth of 19.0% in Q3 2025, against a decline of 44.1% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $666 million (Q2 2026), $637.6 million (Q1 2026) and $662.5 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 65.26 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 37.48 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 38.94 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 34.36 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 16.55 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 45.01 Bn |
| 10 | Emergent BioSolutions | 310.37 Mn | -370.73 Mn | 29.20 Mn | 558.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 558.20 Mn |
| Jun 30, 2026 | 666.00 Mn |
| Mar 31, 2026 | 637.60 Mn |
| Dec 31, 2025 | 662.50 Mn |
| Sep 30, 2025 | 786.90 Mn |
| Jun 30, 2025 | 719.50 Mn |
| Mar 31, 2025 | 706.80 Mn |
| Dec 31, 2024 | 598.70 Mn |
| Sep 30, 2024 | 661.40 Mn |
| Jun 30, 2024 | 654.50 Mn |
| Mar 31, 2024 | 682.40 Mn |
| Dec 31, 2023 | 679.50 Mn |
| Sep 30, 2023 | 720.80 Mn |
| Jun 30, 2023 | 777.70 Mn |
| Mar 31, 2023 | 1.22 Bn |
| Dec 31, 2022 | 1.21 Bn |
| Sep 30, 2022 | 1.10 Bn |
| Jun 30, 2022 | 1.08 Bn |
| Mar 31, 2022 | 1.10 Bn |
| Dec 31, 2021 | 1.27 Bn |
API Access
Emergent BioSolutions Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();